Skip to content

Exercise Effects in Children With Attention Deficit Hyperactivity Disorder

Catecholamine and Cognitive Response to Exercise in Children With Attention Deficit Hyperactivity Disorder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00945971
Enrollment
45
Registered
2009-07-24
Start date
2019-10-01
Completion date
2020-12-01
Last updated
2019-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit/Hyperactivity Disorder

Keywords

Attention Deficit Hyperactivity Disorder, Catecholamine, Children, Physical Activity

Brief summary

The study will investigate catecholamines responses, and cognitive effects of exercise in children with attention deficit hyperactivity disorder, and the effect of exercise training on these measures.

Detailed description

A leading pathophysiologic hypothesis of attention-deficit/hyperactivity disorder (ADHD) is based on the notion of a catecholamine \[CA; norepinephrine (NE), epinephrine (EPI), and dopamine (DA)\] dysfunction. This hypothesis suggests that the CA response to environmental stimuli is attenuated in ADHD and is derived primarily from observations that drugs such as methylphenidate and amphetamine - considered to be CA agonists - are effective in treating the symptoms of ADHD. Despite this compelling evidence, a definitive role of CA responsiveness in ADHD remains controversial. Physical activity is widely known to be a powerful stimulus of the hypothalamic-pituitary-adrenal (HPA) and noradrenergic systems. On the basis of the nation of a CA dysfunction in ADHD, we reasoned that the normal robust increase in circulating CA seen in response to exercise would be blunted in children with ADHD. The objective of this study is to examine the possibility that exercise program and testing might be useful in differentiating CA responses to stress between children who had received a diagnosis of attention-deficit/hyperactivity disorder (ADHD) and age- and gender-matched controls. This study will take place in 'Children and adolescence health and sports center' in Meir Medical Center, Kfar-Saba, Israel. Forty-five children, boys and girls between the ages 6 and 18, with newly diagnosed ADHD that not receiving any drugs will be assigned to the intervention group. Age and gender matched children with ADHD, receiving Ritalin and not engaged in regular exercise, or healthy children's without ADHD will serve as controls. The intervention group will participate in an exercise program, including aerobic and anaerobic components, twice a week, for 3 months. Exercise testing, blood sampling and cognitive assessment will be performed at the start and in the end of this study.

Interventions

OTHERPhysical activity

The intervention group will engage in exercise program, including aerobic and anaerobic components,twice a week, for 3 months. Exercise testing, blood sampling and cognitive assessment will be used at the start and in the end of this study.

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* boys and girls between the ages 6 and 18, with newly diagnosed ADHD.

Exclusion criteria

* children with ADHD on medications

Design outcomes

Primary

MeasureTime frameDescription
Catecholamine (Epinephrine, NorEpinephrine, Dopamine) blood levelsbaseline and after 3 months intervention
Exercise testingbaseline and after 3 months intervention
cognitive assessmentbaseline and after 3 months interventionwill be performed at the start and in the end of the intervention (time 0 and 3 months).

Countries

Israel

Contacts

Primary ContactDan Nemet, MD
dan.nemet@clalit.org.il972-9-7472134
Backup ContactAlon Eliakim, MD
eliakim.alon@clalit.org.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026